Also trades as: GLTO (NASDAQ) · $vol 5M
DMRA NASDAQ
Galecto, Inc.
1W: +4.1%
1M: -9.0%
YTD: +0.5%
$24.15
+0.11 (+0.46%)
After Hours: $24.48 (+0.33, +1.37%)
Weekly Expected Move ±7.4%
$21
$23
$25
$26
$28
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$1.4B
52W Range2.45-38.325
Volume246,545
Avg Volume299,400
Beta1.51
Dividend—
Analyst Ratings
Company Info
CEOJennifer A. Jarrett
Employees7
SectorHealthcare
IndustryBiotechnology
IPO Date2026-03-10
Websitegalecto.com
Building 23
Boston, MA 02453
US
Boston, MA 02453
US
781 281 9020
About Galecto, Inc.
Galecto, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3 and LOXL2. The company was founded by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye in 2011 and is headquartered in Boston, MA.
Latest News
What Makes Galecto, Inc. (DMRA) a Strong Momentum Stock: Buy Now?
How Much Upside is Left in DAMORA THERAPEU (DMRA)? Wall Street Analysts Think 73.1%
This Vertiv Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Damora Therapeutics appoints Jennifer Jarrett as CEO
Damora Therapeutics Appoints Biotechnology Leader Jennifer Jarrett as President and Chief Executive Officer; Adds Two Industry Veterans to Board of Directors
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Burkavage Brian | 312,535 | $32.00 | 2026-05-01 | |
| Jarrett Jennifer | A-Award | 1,500,000 | $25.50 | 2026-03-30 |
| Jarrett Jennifer | A-Award | 500,000 | — | 2026-03-30 |
| Jarrett Jennifer | 0 | — | 2026-03-30 | |
| Winslow Garrett | A-Award | 250,000 | $23.05 | 2026-03-23 |